DARRON LEWIS: Open Payments
NPI 1649767658 · VILLA RICA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 25 payments from 13 companies in 2025. Trend: 2023 $16 · 2024 $63 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| Supernus Pharmaceuticals, Inc. | 2 | $70 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Corium, LLC | 3 | $36 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
Products named: CAPLYTA, INGREZZA, FANAPT, Qelbree, REXULTI, Azstarys, AREXVY, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
